---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-030089"
form_type: "8-K"
ticker: "TXMD"
cik: "0000025743"
company_name: "TherapeuticsMD, Inc."
filed_at: "2025-04-09T23:59:59+00:00"
generated_at: "2026-05-23T18:38:23.023495+00:00"
event_type: "litigation"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# TherapeuticsMD files lawsuit against Mayne Pharma for breach of contract over 2022 agreements

## Summary
- Filed April 8, 2025 in U.S. District Court for Delaware (Case No. not assigned).
- Seeks damages for breach of contract, implied covenant, fraudulent inducement, and unjust enrichment.
- Dispute centers on net working capital allowances under License and Transaction Agreements dated December 4, 2022.
- No specified damages amount; litigation outcome uncertain.

## SEC filing metadata
- accession: 0001213900-25-030089
- form_type: 8-K
- ticker: TXMD
- cik: 0000025743
- company_name: TherapeuticsMD, Inc.
- filed_at: 2025-04-09T23:59:59+00:00
- event_type: litigation
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/25743/000121390025030089/0001213900-25-030089-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/25743/000121390025030089/ea0237667-8k_therap.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-030089
- JSON: https://secwatch.observer/filing/0001213900-25-030089.json
- Plain text: https://secwatch.observer/filing/0001213900-25-030089.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.